| Literature DB >> 33143689 |
Hong Zhuang1,2, Xinyi Ding1,2, Ting Zhang1,2, Qing Chang1,2, Gezhi Xu3,4.
Abstract
BACKGROUND: To evaluate the effect and prognostic factors of vitrectomy combined with intravitreal antifungal therapy for posttraumatic fungal endophthalmitis in Eastern China.Entities:
Keywords: Antifungal therapy; Fungal endophthalmitis; Penetrating ocular trauma; Vitrectomy
Mesh:
Substances:
Year: 2020 PMID: 33143689 PMCID: PMC7607652 DOI: 10.1186/s12886-020-01703-7
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Demographic data, onset features, and culture results of patients with fungal endophthalmitis
| Patient No. | Sex | Age (years) | Penetrating object | Time from trauma to endophthalmitis | Pathogenic organism |
|---|---|---|---|---|---|
| 1 | M | 39 | Plant (chestnut thorn) | 3 months | |
| 2 | M | 57 | Plant (chestnut thorn) | 26 days | |
| 3 | F | 64 | Plant (chestnut thorn) | 70 days | |
| 4 | M | 22 | Plant (bamboo stick) | 3 months | |
| 5 | M | 10 | Plant (bamboo stick) | 4 days | |
| 6 | F | 46 | Plant (bamboo stick) | 20 days | |
| 7 | M | 58 | Plant (tree branch) | 28 days | Unidentified mold |
| 8 | M | 66 | Plant (tree branch) | 26 days | |
| 9 | M | 49 | Plant (tree branch) | 18 days | |
| 10 | F | 60 | Plant (wood stick) | 2 months | |
| 11 | M | 67 | Plant (wood stick) | 35 days | |
| 12 | M | 57 | Plant (wood stick) | 9 days | Unidentified mold |
| 13 | M | 44 | Metal (iron scurf) | 35 days | |
| 14 | M | 7 | Metal (iron scurf) | 3 days | Unidentified mold |
| 15 | M | 49 | Metal (iron nail) | 40 days | |
| 16 | M | 27 | Metal (iron nail) | 40 days | Unidentified mold |
| 17 | M | 20 | Metal (iron wire) | 18 days | |
| 18 | M | 33 | Metal (iron wire) | 16 days | |
| 19 | M | 48 | Metal (iron wire) | 25 days | |
| 20 | M | 31 | Metal (iron wire) | 12 days | |
| 21 | M | 64 | Metal (iron wire) | 38 days | Aspergillus |
| 22 | M | 58 | Metal (iron wire) | 22 days | |
| 23 | F | 8 | Metal (iron wire) | 28 days | Dematiaceous mold |
| 24 | M | 69 | Metal (iron wire) | 12 days | |
| 25 | M | 47 | Metal (iron wire) | 7 days | |
| 26 | F | 47 | Metal (iron wire) | 20 days | |
| 27 | M | 34 | Metal (iron wire) | 35 days | |
| 28 | M | 57 | Metal (iron wire) | 11 days | |
| 29 | M | 43 | Metal (copper key) | 2 months | |
| 30 | M | 47 | Other (plastic object) | 40 days | |
| 31 | F | 40 | Other (plastic object) | 75 days | |
| 32 | F | 53 | Other (plastic object) | 4 months | Unidentified mold |
| 33 | M | 52 | Other (brick fragments) | 26 days | |
| 34 | F | 54 | Other (ceramic fragments) | 4 months | |
| 35 | M | 69 | Other (crushed stone) | 25 days |
Fig. 1Examination images of patient no. 13. a Anterior segment photograph at 1 day after corneal repair; b. Anterior segment photograph at 35 days after corneal repair; c. Thirty-five days after corneal repair, ultrasound biomicroscopy showed a hyperechoic lesion at the temporal posterior iris. d. Eleven months after vitrectomy, an anterior segment photograph showed a central corneal scar and excision of the temporal iris
Treatments and visual outcomes in patients with fungal endophthalmitis
| Patient No. | VA at presentation | First PPV | Subsequent PPV or IVI | Final VA |
|---|---|---|---|---|
| 1 | HM | PPV, LE, IVI* | PPV, IE, SO, IVI (Vori) | HM |
| 2 | HM | PPV, LE, IVI* | PPV, SO, IVI (Vori) | HM |
| 3 | LP | PPV, LE, SO, IVI (Vori) | NA | HM |
| 4 | HM | PPV, LE, SO, IVI (AmB) | NA | LP |
| 5 | HM | PPV, LE, IVI* | IVI (Vori) | 20/250 |
| 6 | LP | PPV, LE, IVI (AmB) | NA | HM |
| 7 | HM | PPV, LE, IVI (Vori) | PPV, SO, IVI (Vori) | LP |
| 8 | LP | PPV, LE, IVI (Vori) | NA | LP |
| 9 | LP | PPV, LE, IVI (AmB) | NA | LP |
| 10 | LP | PPV, LE, IVI* | PPV, IVI (Vori) | LP |
| 11 | HM | PPV, LE, IVI (AmB) | NA | CF |
| 12 | HM | PPV, LE, IVI* | PPV, SO, IVI (Vori) | HM |
| 13 | LP | PPV, LE, IE, SO, IVI (Vori) | NA | 20/200 |
| 14 | LP | PPV, LE, IVI (AmB) | NA | HM |
| 15 | HM | PPV, LE, IVI (Vori) | NA | 20/100 |
| 16 | LP | PPV, LE, IVI* | IVI (AmB); enucleation | NLP |
| 17 | LP | PPV, LE, IVI* | IVI (AmB); PPV, IE, SO, IVI (AmB) | 20/400 |
| 18 | HM | PPV, LE, IVI (AmB) | NA | 20/400 |
| 19 | CF | PPV, LE, IVI* | IVI (AmB); PPV, IE, SO, IVI (AmB) | HM |
| 20 | LP | PPV, LE, SO, IVI (AmB) | NA | 20/50 |
| 21 | HM | PPV, LE, IVI* | PPV, IVI (AmB) | HM |
| 22 | LP | PPV, LE, IVI* | IVI (AmB) | CF |
| 23 | LP | PPV, LE, IVI* | PPV, SO, IVI (Vori) | HM |
| 24 | LP | PPV, LE, IVI (AmB) | NA | LP |
| 25 | LP | PPV, LE, IVI (AmB) | NA | CF |
| 26 | HM | PPV,LE,IVI (AmB) | NA | 20/400 |
| 27 | HM | PPV,LE,SO,IVI (AmB) | NA | 20/250 |
| 28 | HM | PPV,LE,IVI (Vori) | PPV,SO,IVI (Vori) | 20/400 |
| 29 | LP | PPV, LE, IVI* | PPV, SO, IVI (Vori) | LP |
| 30 | LP | PPV, LE, IVI (AmB) | NA | 20/400 |
| 31 | LP | PPV, LE, IVI* | IVI (AmB); enucleation | NLP |
| 32 | LP | PPV, LE, IVI* | IVI (Vori) | LP |
| 33 | HM | PPV, LE, IVI* | PPV, IVI (Vori) | 20/160 |
| 34 | HM | PPV, LE, IVI (AmB) | NA | 20/40 |
| 35 | LP | PPV, LE, IVI* | IVI (AmB) | LP |
VA visual acuity, IVI intravitreal injection, *IVI antibiotics (ceftazidime + norvancomycin), PPV pars plana vitrectomy, LE lensectomy, IE iridectomy, SO silicone oil, Vori voriconazole, AmB amphotericin B, NA not applicable, NLP no light perception, LP light perception, HM hand motion, CF counting fingers
Visual acuity before and after vitrectomy in eyes with fungal endophthalmitis
| Time | NLP | LP | HM | CF | 20/400 or better |
|---|---|---|---|---|---|
| Before surgery | 0 | 19 | 15 | 1 | 0 |
| After surgery | 2 | 9 | 9 | 3 | 12 |
Values are number of eyes.
NLP no light perception, LP light perception, HM hand motion, CF counting fingers
Visual outcomes of eyes divided into two groups according to preoperative vision
| Group | Preoperative vision | Final visual acuity | Total | ||||
|---|---|---|---|---|---|---|---|
| NLP | LP | HM | CF | 20/400 or better | |||
| Group 1A | LP | 2 | 7 | 4 | 2 | 4 | 19 |
| Group 1B | better than LP | 0 | 2 | 5 | 1 | 8 | 16 |
Values are number of eyes.
NLP no light perception, LP light perception
Visual outcomes of eyes divided into two groups according to whether an antifungal drug was injected during the first vitrectomy
| Group | IVI antifungal drug in the first vitrectomy | Final visual acuity | Total | ||||
|---|---|---|---|---|---|---|---|
| NLP | LP | HM | CF | 20/400 or better | |||
| Group 2A | Yes | 0 | 5 | 3 | 2 | 9 | 19 |
| Group 2B | No | 2 | 4 | 6 | 1 | 3 | 16 |
Values are number of eyes.
IVI intravitreal injection, NLP no light perception, LP light perception, HM hand motion, CF counting fingers